COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.

Journal: GE Portuguese journal of gastroenterology
Published Date:

Abstract

INTRODUCTION: Three years after the beginning of the SARS-CoV-2 pandemic, the safety and efficacy of COVID-19 vaccination in liver cirrhosis (LC) patients remain controversial. We aimed to study the safety, immunological, and clinical responses of LC patients to COVID-19 vaccination.

Authors

  • Inês Canha
    Gastroenterology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Mário Jorge Silva
    Gastroenterology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Maria Azevedo Silva
    Gastroenterology Department, Centro Hospitalar de Leiria, Leiria, Portugal.
  • Mara Sarmento Costa
    Gastroenterology Department, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
  • Rita Ornelas Saraiva
    Gastroenterology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • André Ruge
    Gastroenterology Department, Centro Hospitalar de Leiria, Leiria, Portugal.
  • Mariana Verdelho Machado
    Gastroenterology Department, Hospital de Vila Franca de Xira, Vila Franca de Xira, Portugal.
  • Catarina Sousa Félix
    Gastroenterology Department, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
  • Bárbara Morão
    Gastroenterology Department, Hospital Beatriz Ângelo, Lisbon, Portugal.
  • Pedro Narra Figueiredo
    Gastroenterology Department, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal.
  • Milena Mendes
    Gastroenterology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
  • Carina Leal
    Gastroenterology Department, Centro Hospitalar de Leiria, Leiria, Portugal.
  • Filipe Calinas
    Gastroenterology Department, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

Keywords

No keywords available for this article.